$MNZO Income Statement

Manzo Pharmaceuticals, Inc. (MNZO)

Income Statement

Get Income Statement for:

View: Annual Data | Quarterly Data

All numbers in thousands

Period Ending		Dec 31, 2014	Sep 30, 2014	Jun 30, 2014	Mar 31, 2014
Total Revenue		0	1	–	–
Cost of Revenue		–	–	–	–

Gross Profit		0	1	–	–

	Operating Expenses
	Research Development	–	–	–	–
	Selling General and Administrative	–	–	–	–
	Non Recurring	–	–	–	–
	Others	–	–	–	–

	Total Operating Expenses	–	–	–	–


Operating Income or Loss		3,009	(2,995)	(130)	(130)

	Income from Continuing Operations
	Total Other Income/Expenses Net	(199)	–	–	–
	Earnings Before Interest And Taxes	2,811	(2,999)	(130)	(130)
	Interest Expense	(5,788)	6,328	–	–
	Income Before Tax	8,598	(9,328)	(130)	(130)
	Income Tax Expense	–	–	–	–
	Minority Interest	–	–	–	–

	Net Income From Continuing Ops	8,598	(9,328)	(130)	(130)

	Non-recurring Events
	Discontinued Operations	–	–	–	–
	Extraordinary Items	–	–	–	–
	Effect Of Accounting Changes	–	–	–	–
	Other Items	–	–	–	–


Net Income		8,598	(9,328)	(130)	(130)
Preferred Stock And Other Adjustments		–	–	–	–

Net Income Applicable To Common Shares		8,598	(9,328)	(130)	(130)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com